Involvement of the infundibulopelvic ligament in ovarian cancer may be associated with decreased survival and related to paraaortic lymph node metastasis
◦ Patients with epithelial ovarian cancer, including high- and low-grade serous, high- and low-grade endometrioid, mucinous (expansile and infiltrative types), and carcinosarcoma.
FIGO 2014 stage IA-IVB.
Patients undergoing primary surgery or interval surgery after 3-4 or 6 cycles of chemtherapy
Patients with no residual disease after surgery.
◦ Patients without epithelial ovarian cancer.
Patients with ECOG 2-4.
Patients who do not consent to participate in the study.
Patients who did not undergo complete staging surgery (including hysterectomy, bilateral salpingo-oophorectomy, pelvic and para-aortic lymphadenectomy, and omentectomy) or with residual disease after cytoreductive surgery.
Patients with FIGO stage IA-IVB epithelial ovarian cancer who undergoing surgery at our center.
Cohort
Prospective
resection of infundibulopelvic ligament
Other interventionTherefore, this study also aims to perform bilateral infundibulopelvic ligament resection (at least 8 cm in length) during surgery for ovarian cancer patients
metastasis in infundibulopelvic ligament
To analyze the percentage of infundibulopelvic ligament involvement by cancer in patients with FIGO stage IA-IVB ovarian cancer.
Presence of paraaortic lymph node metastasis
Evaluation of histologically positive para-aortic lymph nodes in patients with metastasis in the infundibulopelvic ligament
Disease Free Survival
Impact of infundibulopelvic ligament involvement on Disease specific survival
Assessment of complications
Assessment of perioperative complications and site effects of infundibulopelvic ligament resection
Overall survival (OS)
Impact of infundibulopelvic ligament involvement on overall survival
Click on the lead sponsor to view all of their trials.
